[O05] Oral Session 5　Bioinformatics

[O5-3] Prediction of chaperone drug amenability for GLA variants in Fabry disease

Yuji Sakahashi¹, Yohei Miyashita^2,3, Yasuki Ishihara³, Manami Hama², Osamu Yamaguchi^1,4, Yoshihiro Asano^2,3 (1.Omics Research Center, National Cerebral and Cardiovascular Center, Suita, Japan, 2.Department of Genomic Medicine, National Cerebral and Cardiovascular Center, Osaka, Japan, 3.Biobank, Open Innovation Center, National Cerebral and Cardiovascular Center, Osaka, Japan, 4.Department of Cardiology, Pulmonology, Nephrology, and Hypertension, Ehime University, Ehime, Japan)

Password required to view

Log in

or